Skip to main content
Figure 4 | BMC Medical Research Methodology

Figure 4

From: Adjustment for reporting bias in network meta-analysis of antidepressant trials

Figure 4

Cumulative ranking probability plots for the 12 antidepressant agents from the standard NMA model applied to FDA data (bold solid line) and published data (bold dotted line) and from the 2 adjustment models applied to published data (regression model in plain dashed line and selection model in plain double-dashed line). On each plot, the x-axis shows possible ranks from r = 1 up to r = 13 and the y-axis shows the cumulative probabilities that the corresponding treatment is among the top r treatments. The closer the curve is to the upper left corner, the better the treatment. The surface under the cumulative ranking line is 1 when a treatment is the best and 0 when a treatment is the worst. FDA: standard NMA model applied to FDA data (bold plain line); Pub.: standard NMA model applied to published data (bold dash line); Reg.: regression model applied to published data (dash line); Sln.: selection model applied to published data (long-dash short-dash line).

Back to article page